Emergency room patients given ketamine and antispychotic drugs without their knowledge or consent.

According to an article in STAT https://www.statnews.com/2018/10/29/er-patients-given-ketamine-powerful-drugs-without-consent/?utm_source=STAT+Newsletters&utm_campaign=56d4d18dfb-Daily_Recap&utm_medium=email&utm_term=0_8cab1d7961-56d4d18dfb-118516237, a Minnesota hospital tested powerful antipsychotics andĀŒ potent anesthetic on emergency room patients without their knowledge or consent. This is a violation of law say federal inspectors have determined. According to FDA inspectors, the hospital's Institutional Review Board...
Continue reading…

Abbott Labs and Abbvie Inc. pay $25 million to settle with Government on allegations of kickbacks and off label marketing of TriCor

Pharmaceutical companies Abbott Laboratories and AbbVie Inc. (ā€œAbbottā€) will pay $25 million to settle federal allegations that it paid kickbacks and unlawfully marketed and promotedĀ the drug TriCorĀ® for: (1) use in treating, preventing, or reducing cardiovascular events and other cardiac health risk; (2) use in combination with statin drugs, and (3) use...
Continue reading…

FDA okays new drug to treat influenza

The U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours. "This is the first new antiviral flu treatment with a novel mechanism of action approved...
Continue reading…